Global Nuclear Receptor ROR-Gamma Market Growth (Status and Outlook) 2025-2031

October 2025 | 134 pages | ID: G4438E804C38EN
LP Information

Abstracts

According to this study, the global Nuclear Receptor ROR-Gamma market size will reach US$ million by 2031.

United States market for Nuclear Receptor ROR-Gamma is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Nuclear Receptor ROR-Gamma is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Nuclear Receptor ROR-Gamma is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Nuclear Receptor ROR-Gamma players cover 4SC AG, Advinus Therapeutics Ltd., Arrien Pharmaceuticals, LLC, Aurigene Discovery Technologies Limited, Biogen, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the ?Nuclear Receptor ROR-Gamma Industry Forecast? looks at past sales and reviews total world Nuclear Receptor ROR-Gamma sales in 2024, providing a comprehensive analysis by region and market sector of projected Nuclear Receptor ROR-Gamma sales for 2025 through 2031. With Nuclear Receptor ROR-Gamma sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Receptor ROR-Gamma industry.

This Insight Report provides a comprehensive analysis of the global Nuclear Receptor ROR-Gamma landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nuclear Receptor ROR-Gamma portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Nuclear Receptor ROR-Gamma market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Receptor ROR-Gamma and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Receptor ROR-Gamma.

This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Receptor ROR-Gamma market by product type, application, key players and key regions and countries.

Segmentation by Type:

• VPR-66
• INV-17
• GSK-2981278
• BBI-6000
• Others

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• 4SC AG
• Advinus Therapeutics Ltd.
• Arrien Pharmaceuticals, LLC
• Aurigene Discovery Technologies Limited
• Biogen, Inc.
• Brickell Biotech, Inc.
• Bristol-Myers Squibb Company
• Celgene Corporation
• Genentech, Inc.
• Genfit SA
• GlaxoSmithKline Plc
• Hanmi Pharmaceuticals, Co. Ltd.
• Karo Bio AB
• Lead Pharma Holding B.V.
• Nuevolution AB
• Phenex Pharmaceuticals AG
• Reata Pharmaceuticals, Inc.
• Teijin Pharma Limited
• Visionary Pharmaceuticals, Inc.
• Vitae Pharmaceuticals, Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nuclear Receptor ROR-Gamma Market Size (2020-2031)
  2.1.2 Nuclear Receptor ROR-Gamma Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Nuclear Receptor ROR-Gamma by Country/Region (2020, 2024 & 2031)
2.2 Nuclear Receptor ROR-Gamma Segment by Type
  2.2.1 VPR-66
  2.2.2 INV-17
  2.2.3 GSK-2981278
  2.2.4 BBI-6000
  2.2.5 Others
2.3 Nuclear Receptor ROR-Gamma Market Size by Type
  2.3.1 Nuclear Receptor ROR-Gamma Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Nuclear Receptor ROR-Gamma Market Size Market Share by Type (2020-2025)
2.4 Nuclear Receptor ROR-Gamma Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Nuclear Receptor ROR-Gamma Market Size by Application
  2.5.1 Nuclear Receptor ROR-Gamma Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Nuclear Receptor ROR-Gamma Market Size Market Share by Application (2020-2025)

3 NUCLEAR RECEPTOR ROR-GAMMA MARKET SIZE BY PLAYER

3.1 Nuclear Receptor ROR-Gamma Market Size Market Share by Player
  3.1.1 Global Nuclear Receptor ROR-Gamma Revenue by Player (2020-2025)
  3.1.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Player (2020-2025)
3.2 Global Nuclear Receptor ROR-Gamma Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NUCLEAR RECEPTOR ROR-GAMMA BY REGION

4.1 Nuclear Receptor ROR-Gamma Market Size by Region (2020-2025)
4.2 Global Nuclear Receptor ROR-Gamma Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nuclear Receptor ROR-Gamma Market Size Growth (2020-2025)
4.4 APAC Nuclear Receptor ROR-Gamma Market Size Growth (2020-2025)
4.5 Europe Nuclear Receptor ROR-Gamma Market Size Growth (2020-2025)
4.6 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Nuclear Receptor ROR-Gamma Market Size by Country (2020-2025)
5.2 Americas Nuclear Receptor ROR-Gamma Market Size by Type (2020-2025)
5.3 Americas Nuclear Receptor ROR-Gamma Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nuclear Receptor ROR-Gamma Market Size by Region (2020-2025)
6.2 APAC Nuclear Receptor ROR-Gamma Market Size by Type (2020-2025)
6.3 APAC Nuclear Receptor ROR-Gamma Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Nuclear Receptor ROR-Gamma Market Size by Country (2020-2025)
7.2 Europe Nuclear Receptor ROR-Gamma Market Size by Type (2020-2025)
7.3 Europe Nuclear Receptor ROR-Gamma Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nuclear Receptor ROR-Gamma by Region (2020-2025)
8.2 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2020-2025)
8.3 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NUCLEAR RECEPTOR ROR-GAMMA MARKET FORECAST

10.1 Global Nuclear Receptor ROR-Gamma Forecast by Region (2026-2031)
  10.1.1 Global Nuclear Receptor ROR-Gamma Forecast by Region (2026-2031)
  10.1.2 Americas Nuclear Receptor ROR-Gamma Forecast
  10.1.3 APAC Nuclear Receptor ROR-Gamma Forecast
  10.1.4 Europe Nuclear Receptor ROR-Gamma Forecast
  10.1.5 Middle East & Africa Nuclear Receptor ROR-Gamma Forecast
10.2 Americas Nuclear Receptor ROR-Gamma Forecast by Country (2026-2031)
  10.2.1 United States Market Nuclear Receptor ROR-Gamma Forecast
  10.2.2 Canada Market Nuclear Receptor ROR-Gamma Forecast
  10.2.3 Mexico Market Nuclear Receptor ROR-Gamma Forecast
  10.2.4 Brazil Market Nuclear Receptor ROR-Gamma Forecast
10.3 APAC Nuclear Receptor ROR-Gamma Forecast by Region (2026-2031)
  10.3.1 China Nuclear Receptor ROR-Gamma Market Forecast
  10.3.2 Japan Market Nuclear Receptor ROR-Gamma Forecast
  10.3.3 Korea Market Nuclear Receptor ROR-Gamma Forecast
  10.3.4 Southeast Asia Market Nuclear Receptor ROR-Gamma Forecast
  10.3.5 India Market Nuclear Receptor ROR-Gamma Forecast
  10.3.6 Australia Market Nuclear Receptor ROR-Gamma Forecast
10.4 Europe Nuclear Receptor ROR-Gamma Forecast by Country (2026-2031)
  10.4.1 Germany Market Nuclear Receptor ROR-Gamma Forecast
  10.4.2 France Market Nuclear Receptor ROR-Gamma Forecast
  10.4.3 UK Market Nuclear Receptor ROR-Gamma Forecast
  10.4.4 Italy Market Nuclear Receptor ROR-Gamma Forecast
  10.4.5 Russia Market Nuclear Receptor ROR-Gamma Forecast
10.5 Middle East & Africa Nuclear Receptor ROR-Gamma Forecast by Region (2026-2031)
  10.5.1 Egypt Market Nuclear Receptor ROR-Gamma Forecast
  10.5.2 South Africa Market Nuclear Receptor ROR-Gamma Forecast
  10.5.3 Israel Market Nuclear Receptor ROR-Gamma Forecast
  10.5.4 Turkey Market Nuclear Receptor ROR-Gamma Forecast
10.6 Global Nuclear Receptor ROR-Gamma Forecast by Type (2026-2031)
10.7 Global Nuclear Receptor ROR-Gamma Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Nuclear Receptor ROR-Gamma Forecast

11 KEY PLAYERS ANALYSIS

11.1 4SC AG
  11.1.1 4SC AG Company Information
  11.1.2 4SC AG Nuclear Receptor ROR-Gamma Product Offered
  11.1.3 4SC AG Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 4SC AG Main Business Overview
  11.1.5 4SC AG Latest Developments
11.2 Advinus Therapeutics Ltd.
  11.2.1 Advinus Therapeutics Ltd. Company Information
  11.2.2 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product Offered
  11.2.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Advinus Therapeutics Ltd. Main Business Overview
  11.2.5 Advinus Therapeutics Ltd. Latest Developments
11.3 Arrien Pharmaceuticals, LLC
  11.3.1 Arrien Pharmaceuticals, LLC Company Information
  11.3.2 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product Offered
  11.3.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Arrien Pharmaceuticals, LLC Main Business Overview
  11.3.5 Arrien Pharmaceuticals, LLC Latest Developments
11.4 Aurigene Discovery Technologies Limited
  11.4.1 Aurigene Discovery Technologies Limited Company Information
  11.4.2 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Offered
  11.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Aurigene Discovery Technologies Limited Main Business Overview
  11.4.5 Aurigene Discovery Technologies Limited Latest Developments
11.5 Biogen, Inc.
  11.5.1 Biogen, Inc. Company Information
  11.5.2 Biogen, Inc. Nuclear Receptor ROR-Gamma Product Offered
  11.5.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Biogen, Inc. Main Business Overview
  11.5.5 Biogen, Inc. Latest Developments
11.6 Brickell Biotech, Inc.
  11.6.1 Brickell Biotech, Inc. Company Information
  11.6.2 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product Offered
  11.6.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Brickell Biotech, Inc. Main Business Overview
  11.6.5 Brickell Biotech, Inc. Latest Developments
11.7 Bristol-Myers Squibb Company
  11.7.1 Bristol-Myers Squibb Company Company Information
  11.7.2 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Offered
  11.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Bristol-Myers Squibb Company Main Business Overview
  11.7.5 Bristol-Myers Squibb Company Latest Developments
11.8 Celgene Corporation
  11.8.1 Celgene Corporation Company Information
  11.8.2 Celgene Corporation Nuclear Receptor ROR-Gamma Product Offered
  11.8.3 Celgene Corporation Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Celgene Corporation Main Business Overview
  11.8.5 Celgene Corporation Latest Developments
11.9 Genentech, Inc.
  11.9.1 Genentech, Inc. Company Information
  11.9.2 Genentech, Inc. Nuclear Receptor ROR-Gamma Product Offered
  11.9.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Genentech, Inc. Main Business Overview
  11.9.5 Genentech, Inc. Latest Developments
11.10 Genfit SA
  11.10.1 Genfit SA Company Information
  11.10.2 Genfit SA Nuclear Receptor ROR-Gamma Product Offered
  11.10.3 Genfit SA Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Genfit SA Main Business Overview
  11.10.5 Genfit SA Latest Developments
11.11 GlaxoSmithKline Plc
  11.11.1 GlaxoSmithKline Plc Company Information
  11.11.2 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Offered
  11.11.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 GlaxoSmithKline Plc Main Business Overview
  11.11.5 GlaxoSmithKline Plc Latest Developments
11.12 Hanmi Pharmaceuticals, Co. Ltd.
  11.12.1 Hanmi Pharmaceuticals, Co. Ltd. Company Information
  11.12.2 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product Offered
  11.12.3 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Hanmi Pharmaceuticals, Co. Ltd. Main Business Overview
  11.12.5 Hanmi Pharmaceuticals, Co. Ltd. Latest Developments
11.13 Karo Bio AB
  11.13.1 Karo Bio AB Company Information
  11.13.2 Karo Bio AB Nuclear Receptor ROR-Gamma Product Offered
  11.13.3 Karo Bio AB Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Karo Bio AB Main Business Overview
  11.13.5 Karo Bio AB Latest Developments
11.14 Lead Pharma Holding B.V.
  11.14.1 Lead Pharma Holding B.V. Company Information
  11.14.2 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product Offered
  11.14.3 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Lead Pharma Holding B.V. Main Business Overview
  11.14.5 Lead Pharma Holding B.V. Latest Developments
11.15 Nuevolution AB
  11.15.1 Nuevolution AB Company Information
  11.15.2 Nuevolution AB Nuclear Receptor ROR-Gamma Product Offered
  11.15.3 Nuevolution AB Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Nuevolution AB Main Business Overview
  11.15.5 Nuevolution AB Latest Developments
11.16 Phenex Pharmaceuticals AG
  11.16.1 Phenex Pharmaceuticals AG Company Information
  11.16.2 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Offered
  11.16.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 Phenex Pharmaceuticals AG Main Business Overview
  11.16.5 Phenex Pharmaceuticals AG Latest Developments
11.17 Reata Pharmaceuticals, Inc.
  11.17.1 Reata Pharmaceuticals, Inc. Company Information
  11.17.2 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered
  11.17.3 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 Reata Pharmaceuticals, Inc. Main Business Overview
  11.17.5 Reata Pharmaceuticals, Inc. Latest Developments
11.18 Teijin Pharma Limited
  11.18.1 Teijin Pharma Limited Company Information
  11.18.2 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Offered
  11.18.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.18.4 Teijin Pharma Limited Main Business Overview
  11.18.5 Teijin Pharma Limited Latest Developments
11.19 Visionary Pharmaceuticals, Inc.
  11.19.1 Visionary Pharmaceuticals, Inc. Company Information
  11.19.2 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered
  11.19.3 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.19.4 Visionary Pharmaceuticals, Inc. Main Business Overview
  11.19.5 Visionary Pharmaceuticals, Inc. Latest Developments
11.20 Vitae Pharmaceuticals, Inc.
  11.20.1 Vitae Pharmaceuticals, Inc. Company Information
  11.20.2 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered
  11.20.3 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025)
  11.20.4 Vitae Pharmaceuticals, Inc. Main Business Overview
  11.20.5 Vitae Pharmaceuticals, Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Nuclear Receptor ROR-Gamma Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Nuclear Receptor ROR-Gamma Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of VPR-66
Table 4. Major Players of INV-17
Table 5. Major Players of GSK-2981278
Table 6. Major Players of BBI-6000
Table 7. Major Players of Others
Table 8. Nuclear Receptor ROR-Gamma Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Nuclear Receptor ROR-Gamma Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Type (2020-2025)
Table 11. Nuclear Receptor ROR-Gamma Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Nuclear Receptor ROR-Gamma Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Application (2020-2025)
Table 14. Global Nuclear Receptor ROR-Gamma Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Player (2020-2025)
Table 16. Nuclear Receptor ROR-Gamma Key Players Head office and Products Offered
Table 17. Nuclear Receptor ROR-Gamma Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Nuclear Receptor ROR-Gamma Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Region (2020-2025)
Table 22. Global Nuclear Receptor ROR-Gamma Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Nuclear Receptor ROR-Gamma Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Nuclear Receptor ROR-Gamma Market Size Market Share by Country (2020-2025)
Table 26. Americas Nuclear Receptor ROR-Gamma Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Nuclear Receptor ROR-Gamma Market Size Market Share by Type (2020-2025)
Table 28. Americas Nuclear Receptor ROR-Gamma Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Nuclear Receptor ROR-Gamma Market Size Market Share by Application (2020-2025)
Table 30. APAC Nuclear Receptor ROR-Gamma Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Nuclear Receptor ROR-Gamma Market Size Market Share by Region (2020-2025)
Table 32. APAC Nuclear Receptor ROR-Gamma Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Nuclear Receptor ROR-Gamma Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Nuclear Receptor ROR-Gamma Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Nuclear Receptor ROR-Gamma Market Size Market Share by Country (2020-2025)
Table 36. Europe Nuclear Receptor ROR-Gamma Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Nuclear Receptor ROR-Gamma Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Nuclear Receptor ROR-Gamma
Table 42. Key Market Challenges & Risks of Nuclear Receptor ROR-Gamma
Table 43. Key Industry Trends of Nuclear Receptor ROR-Gamma
Table 44. Global Nuclear Receptor ROR-Gamma Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Nuclear Receptor ROR-Gamma Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Nuclear Receptor ROR-Gamma Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Nuclear Receptor ROR-Gamma Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. 4SC AG Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 49. 4SC AG Nuclear Receptor ROR-Gamma Product Offered
Table 50. 4SC AG Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. 4SC AG Main Business
Table 52. 4SC AG Latest Developments
Table 53. Advinus Therapeutics Ltd. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 54. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product Offered
Table 55. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Advinus Therapeutics Ltd. Main Business
Table 57. Advinus Therapeutics Ltd. Latest Developments
Table 58. Arrien Pharmaceuticals, LLC Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 59. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product Offered
Table 60. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Arrien Pharmaceuticals, LLC Main Business
Table 62. Arrien Pharmaceuticals, LLC Latest Developments
Table 63. Aurigene Discovery Technologies Limited Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 64. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Offered
Table 65. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Aurigene Discovery Technologies Limited Main Business
Table 67. Aurigene Discovery Technologies Limited Latest Developments
Table 68. Biogen, Inc. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 69. Biogen, Inc. Nuclear Receptor ROR-Gamma Product Offered
Table 70. Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Biogen, Inc. Main Business
Table 72. Biogen, Inc. Latest Developments
Table 73. Brickell Biotech, Inc. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 74. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product Offered
Table 75. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Brickell Biotech, Inc. Main Business
Table 77. Brickell Biotech, Inc. Latest Developments
Table 78. Bristol-Myers Squibb Company Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 79. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Offered
Table 80. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Bristol-Myers Squibb Company Main Business
Table 82. Bristol-Myers Squibb Company Latest Developments
Table 83. Celgene Corporation Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 84. Celgene Corporation Nuclear Receptor ROR-Gamma Product Offered
Table 85. Celgene Corporation Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Celgene Corporation Main Business
Table 87. Celgene Corporation Latest Developments
Table 88. Genentech, Inc. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 89. Genentech, Inc. Nuclear Receptor ROR-Gamma Product Offered
Table 90. Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Genentech, Inc. Main Business
Table 92. Genentech, Inc. Latest Developments
Table 93. Genfit SA Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 94. Genfit SA Nuclear Receptor ROR-Gamma Product Offered
Table 95. Genfit SA Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Genfit SA Main Business
Table 97. Genfit SA Latest Developments
Table 98. GlaxoSmithKline Plc Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 99. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Offered
Table 100. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. GlaxoSmithKline Plc Main Business
Table 102. GlaxoSmithKline Plc Latest Developments
Table 103. Hanmi Pharmaceuticals, Co. Ltd. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 104. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product Offered
Table 105. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. Hanmi Pharmaceuticals, Co. Ltd. Main Business
Table 107. Hanmi Pharmaceuticals, Co. Ltd. Latest Developments
Table 108. Karo Bio AB Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 109. Karo Bio AB Nuclear Receptor ROR-Gamma Product Offered
Table 110. Karo Bio AB Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Karo Bio AB Main Business
Table 112. Karo Bio AB Latest Developments
Table 113. Lead Pharma Holding B.V. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 114. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product Offered
Table 115. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. Lead Pharma Holding B.V. Main Business
Table 117. Lead Pharma Holding B.V. Latest Developments
Table 118. Nuevolution AB Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 119. Nuevolution AB Nuclear Receptor ROR-Gamma Product Offered
Table 120. Nuevolution AB Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. Nuevolution AB Main Business
Table 122. Nuevolution AB Latest Developments
Table 123. Phenex Pharmaceuticals AG Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 124. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Offered
Table 125. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 126. Phenex Pharmaceuticals AG Main Business
Table 127. Phenex Pharmaceuticals AG Latest Developments
Table 128. Reata Pharmaceuticals, Inc. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 129. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered
Table 130. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 131. Reata Pharmaceuticals, Inc. Main Business
Table 132. Reata Pharmaceuticals, Inc. Latest Developments
Table 133. Teijin Pharma Limited Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 134. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Offered
Table 135. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 136. Teijin Pharma Limited Main Business
Table 137. Teijin Pharma Limited Latest Developments
Table 138. Visionary Pharmaceuticals, Inc. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 139. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered
Table 140. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 141. Visionary Pharmaceuticals, Inc. Main Business
Table 142. Visionary Pharmaceuticals, Inc. Latest Developments
Table 143. Vitae Pharmaceuticals, Inc. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 144. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered
Table 145. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 146. Vitae Pharmaceuticals, Inc. Main Business
Table 147. Vitae Pharmaceuticals, Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Nuclear Receptor ROR-Gamma Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Nuclear Receptor ROR-Gamma Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Nuclear Receptor ROR-Gamma Sales Market Share by Country/Region (2024)
Figure 8. Nuclear Receptor ROR-Gamma Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Type in 2024
Figure 10. Nuclear Receptor ROR-Gamma in Hospital
Figure 11. Global Nuclear Receptor ROR-Gamma Market: Hospital (2020-2025) & ($ millions)
Figure 12. Nuclear Receptor ROR-Gamma in Clinic
Figure 13. Global Nuclear Receptor ROR-Gamma Market: Clinic (2020-2025) & ($ millions)
Figure 14. Nuclear Receptor ROR-Gamma in Others
Figure 15. Global Nuclear Receptor ROR-Gamma Market: Others (2020-2025) & ($ millions)
Figure 16. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Application in 2024
Figure 17. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Player in 2024
Figure 18. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Region (2020-2025)
Figure 19. Americas Nuclear Receptor ROR-Gamma Market Size 2020-2025 ($ millions)
Figure 20. APAC Nuclear Receptor ROR-Gamma Market Size 2020-2025 ($ millions)
Figure 21. Europe Nuclear Receptor ROR-Gamma Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size 2020-2025 ($ millions)
Figure 23. Americas Nuclear Receptor ROR-Gamma Value Market Share by Country in 2024
Figure 24. United States Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Nuclear Receptor ROR-Gamma Market Size Market Share by Region in 2024
Figure 29. APAC Nuclear Receptor ROR-Gamma Market Size Market Share by Type (2020-2025)
Figure 30. APAC Nuclear Receptor ROR-Gamma Market Size Market Share by Application (2020-2025)
Figure 31. China Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 35. India Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Nuclear Receptor ROR-Gamma Market Size Market Share by Country in 2024
Figure 38. Europe Nuclear Receptor ROR-Gamma Market Size Market Share by Type (2020-2025)
Figure 39. Europe Nuclear Receptor ROR-Gamma Market Size Market Share by Application (2020-2025)
Figure 40. Germany Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 41. France Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Nuclear Receptor ROR-Gamma Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 54. APAC Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 55. Europe Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 57. United States Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 58. Canada Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 59. Mexico Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 60. Brazil Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 61. China Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 62. Japan Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 63. Korea Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 65. India Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 66. Australia Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 67. Germany Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 68. France Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 69. UK Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 70. Italy Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 71. Russia Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 72. Egypt Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 73. South Africa Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 74. Israel Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 75. Turkey Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)
Figure 76. Global Nuclear Receptor ROR-Gamma Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Nuclear Receptor ROR-Gamma Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Nuclear Receptor ROR-Gamma Market Size 2026-2031 ($ millions)